Oncology Company Achieves ~80% Acceleration in Gene Target ID/ Validation

Key Highlights

  • An early-stage US-based pharmaceutical company was studying the effect of gene perturbation on cell fate conversion to develop a novel treatment method for widespread health disorders.
  • Elucidata completed the custom curation process of 50+ datasets in a brief period of 2 months and identified 2 targets that could regulate cell fate reprogramming.
  • Our established curation infrastructure and data processing pipelines increased the overall speed of analysis which helped them identify and validate the targets in 5-6 months instead of the typical time-period of more than a couple of years!

All Case Studies

Request Demo